AXIM Biotechnologies, Inc. (AXIM) stock
AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
AXIM Biotechnologies ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
AXIM Biotechnologies's ebitda for the twelve months ending Jun 30, 2024 was -$1.88M. For fiscal 2023 it was -$2.32M. The highest annual figure on record is -$505.73K in fiscal 2014.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$2.32M | – |
| FY2022 | Dec 31, 2022 | -$4.23M | – |
| FY2021 | Dec 31, 2021 | -$11.86M | – |
| FY2020 | Dec 31, 2020 | -$4.93M | – |
| FY2016 | Dec 31, 2016 | -$3.76M | – |
| FY2015 | Dec 31, 2015 | -$10.05M | – |
| FY2014 | Dec 31, 2014 | -$505.73K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | -$461.31K | – |
| Q1 FY2024 | Mar 31, 2024 | -$293.56K | – |
| Q4 FY2023 | Dec 31, 2023 | -$647.19K | – |
| Q3 FY2023 | Sep 30, 2023 | -$481.78K | – |
| Q2 FY2023 | Jun 30, 2023 | -$590.97K | – |
| Q1 FY2023 | Mar 31, 2023 | -$603.88K | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.04M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.21M | – |
| Q2 FY2022 | Jun 30, 2022 | -$953.88K | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.03M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.55M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.27M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.17M | – |
| Q1 FY2021 | Mar 31, 2021 | -$861.65K | – |
| Q1 FY2020 | Mar 31, 2020 | -$687.89K | – |
| Q3 FY2019 | Sep 30, 2019 | -$482.83K | – |
| Q2 FY2019 | Jun 30, 2019 | -$583.44K | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.29M | – |
| Q3 FY2018 | Sep 30, 2018 | -$934.99K | – |
| Q1 FY2017 | Mar 31, 2017 | -$475.49K | – |
| Q4 FY2016 | Dec 31, 2016 | -$769.38K | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.55M | – |
| Q2 FY2016 | Jun 30, 2016 | -$490.65K | – |
| Q1 FY2016 | Mar 31, 2016 | -$941.34K | – |
| Q4 FY2015 | Dec 31, 2015 | -$6.31M | – |
| Q3 FY2015 | Sep 30, 2015 | -$1.69M | – |
| Q2 FY2015 | Jun 30, 2015 | -$1.56M | – |
| Q1 FY2015 | Mar 31, 2015 | -$488.82K | – |
See a number that looks wrong?